• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/14 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Patent holdings for IPC class C07D 295/14

Total number of patents in this class: 179

10-year publication summary

12
4
4
4
4
4
10
8
6
0
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Alnylam Pharmaceuticals, Inc.
1139
17
Daiichi Sankyo Company, Limited
1873
9
Takeda Pharmaceutical Company Limited
2945
7
Astellas Pharma Inc.
1122
6
Toyama Chemical Co., Ltd.
108
6
Abbvie Inc.
1785
5
Boehringer Ingelheim International GmbH
4750
4
Abbott Laboratories
2462
4
Taisho Pharmaceutical Co., Ltd.
854
4
Pfizer Inc.
3365
3
SK on Co., Ltd.
1402
3
Janssen Pharmaceutica N.V.
3610
2
Vertex Pharmaceuticals Incorporated
1568
2
Actavis Group PTC ehf
506
2
Arena Pharmaceuticals, Inc.
368
2
Bioprojet
49
2
Dainippon Sumitomo Pharma Co., Ltd.
210
2
Dongjin Semichem Co., Ltd.
473
2
Galderma Research & Development
416
2
Gifu University
137
2
Other owners 93